Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37051 - 37075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ELOVL2	54898	upregulated	entinostat results in increased expression of ELOVL2 mRNA	6p24.2	A21035
Entinostat	Investigational	ELP4	26610	downregulated	entinostat results in decreased expression of ELP4 mRNA	11p13	A21037
Entinostat	Investigational	EMILIN2	84034	upregulated	entinostat results in increased expression of EMILIN2 mRNA	18p11.32-p11.31	A21035
Entinostat	Investigational	EML6	400954	upregulated	entinostat results in increased expression of EML6 mRNA	2p16.1	A21035
Entinostat	Investigational	EMP1	2012	upregulated	entinostat results in increased expression of EMP1 mRNA	12p13.1	A21035
Entinostat	Investigational	EMP2	2013	upregulated	entinostat results in increased expression of EMP2 mRNA	16p13.13	A21035
Entinostat	Investigational	EMSY	56946	downregulated	entinostat results in decreased expression of EMSY mRNA	11q13.5	A21037
Entinostat	Investigational	EMX2	2018	downregulated	entinostat results in decreased expression of EMX2 mRNA	10q26.11	A21037
Entinostat	Investigational	ENDOD1	23052	upregulated	entinostat results in increased expression of ENDOD1 mRNA	11q21	A21035
Entinostat	Investigational	ENO2	2026	upregulated	entinostat results in increased expression of ENO2 mRNA	12p13.31	A22509
Entinostat	Investigational	ENO3	2027	upregulated	entinostat results in increased expression of ENO3 mRNA	17p13.2	A21035
Entinostat	Investigational	ENPEP	2028	downregulated	entinostat results in decreased expression of ENPEP mRNA	4q25	A21037
Entinostat	Investigational	ENPP4	22875	upregulated	entinostat results in increased expression of ENPP4 mRNA	6p21.1	A21035
Entinostat	Investigational	ENPP5	59084	upregulated	entinostat results in increased expression of ENPP5 mRNA	6p21.1	A21035
Entinostat	Investigational	ENPP6	133121	upregulated	entinostat results in increased expression of ENPP6 mRNA	4q35.1	A21035
Entinostat	Investigational	ENSA	2029	downregulated	entinostat results in decreased expression of ENSA mRNA	1q21.3	A21035
Entinostat	Investigational	ENTPD1	953	upregulated	entinostat results in increased expression of ENTPD1 mRNA	10q24.1	A21037 A21035
Entinostat	Investigational	EOGT	285203	upregulated	entinostat results in increased expression of EOGT mRNA	3p14.1	A21037
Entinostat	Investigational	EPB41L3	23136	upregulated	entinostat results in increased expression of EPB41L3 mRNA	18p11.31	A21037
Entinostat	Investigational	EPB41L4B	54566	upregulated	entinostat results in increased expression of EPB41L4B mRNA	9q31.3	A21037
Entinostat	Investigational	EPB41L5	57669	upregulated	entinostat results in increased expression of EPB41L5 mRNA	2q14.2	A21037
Entinostat	Investigational	EPC1	80314	downregulated	entinostat results in decreased expression of EPC1 mRNA	10p11.22	A21035
Entinostat	Investigational	EPC2	26122	downregulated	entinostat results in decreased expression of EPC2 mRNA	2q23.1	A21035
Entinostat	Investigational	EPCAM	4072	upregulated	entinostat results in increased expression of EPCAM mRNA	2p21	A21037
Entinostat	Investigational	EPHA1	2041	upregulated	entinostat results in increased expression of EPHA1 mRNA	7q34-q35	A21037

Displaying entries 37051 - 37075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability